This Blue-Chip Firm Is Showing Us the “Fast Lane” to Cannabis Billions

The cannabis market is starting to soar.

The United States is a huge market opportunity, with market projections growing from an estimated $8.5 billion last year to $23.4 billion in 2022, if only a few additional states legalize recreational use. And we’re talking about as much as $50 billion if most states follow the trend.

But the biggest opportunity of all could come in a form people hadn’t been talking about as much…

It’s an opportunity that runs counter to the recreational market trend and the obsession with the cannabinoid THC – the one that causes users to get “high.”

I’m talking about some of the other highly prized cannabinoids present in marijuana – one in particular that one of the world’s biggest, most well-known companies has taken a sudden interest in…

There’s Much More Than THC at Work in Marijuana

My colleagues, friends, and readers have all heard me talk (or seen me write) about cannabidiol (CBD) in terms of its health impact.

It’s just one of the non-psychoactive cannabinoids in cannabis.

Renegade Investment Expert: “It’s time to double down – or even triple down – on your cannabis investments!” Read more…

CBD helps relax people, reduces inflammation, eases pain, and can potentially treat many diseases, including chronic traumatic encephalopathy (CTE), as we discussed earlier this month.

With all those effects, it’s no wonder that it’s also being explored as a potential general health ingredient.

If the health effects of CBD and other cannabinoids prove out, the regulated pharmaceutical market will be unimaginably large – $50 billion, $100 billion, or more.

This past week, an explosive new projection and the rumored participation of a very surprising company both advanced the idea that CBD will be even bigger than THC – even if you don’t count the pharmaceutical market.

The company we’re talking about is one of the largest brands in the world.

It makes perfect sense for this company to be looking at CBD as a health ingredient, since it’s been diversifying away from the product that made it famous for years.

This company owns coffee drinks.

This company owns bottled water brands.

This company owns fruit juice.

This company owns vitamin-infused water.

And in what could play out as a blockbuster, it looks for all the world like it wants to own a cannabis-infused beverage…

Look Who’s “Kicking the Tires” with the Cannabis Industry

Coca Cola Co. (NYSE: KO) is rumored to be seeking a joint venture or other arrangement to make CBD-only beverage products. BNN Bloomberg had the scoop, saying that Coke is looking to make CBD-infused health or “recovery” drinks, which would be positioned similarly to energy drinks or Gatorade.

The shock is how early and quickly Coca-Cola is ready to get into the CBD beverage business.

Urgent Briefing: Discover exactly how to position yourself to cash in after historic new cannabis legislation takes effect – and how to get the names of the top three stocks to buy right away. Click here now

Most market observers believe that the association of CBD with cannabis would have kept companies out of that market until consumer understanding of the difference between CBD and THC increased over time.

For Coke to have its wholesome image associated with cannabis products is a critical endorsement of the changing consumer perception of cannabis and of the potential opportunity a plunge into the CBD business presents.

But the best way to make money on this monumental rise in the CBD market that’s coming isn’t buying Coke’s stock. It’s not even necessarily in grabbing shares of cannabis giant with which Coke is negotiating, either.

The smartest, most lucrative plays are still off the mainstream radar… for now.

Here’s what I mean…

CBD Is a $22 Billion Sub-Industry in the Waiting

The current rumor is that Coca-Cola is talking to Aurora Cannabis Inc. (OTC: ACBFF), one of the four biggest cannabis companies in the world. And because CBD is legal across the United States, there’s no reason it could not also seek a separate domestic deal.

For its part, Aurora – which itself has been involved in a binge of cannabis-related takeovers in the last year – emphasized Tuesday in a carefully worded statement that it has no deal with any beverage company… yet.

First, that can change tomorrow. That’s often how it goes.

Second, it doesn’t matter whether Coke strikes a deal with Aurora or some other cannabis company.

This is a flag in the ground about how serious, how potentially lucrative the legal cannabis market will grow to be.

So, how large is the CBD industry that it’s pushed the largest soft drink company in the world to act?

Brightview, a respected cannabis industry analysis firm, now believes that the CBD-only market worldwide will grow to $22 billion by 2022. That’s in the United States alone. From under $600 million this year, that represents a growth of 132% per year for four years.

Follow topic

Pot Stock InvestingGet real-time marijuana industry news sent directly to your inbox.

Brightview thinks of CBD as the future vanguard of an “anti-pharma” health movement, with people taking daily supplements of CBD, using it to substitute for pharmacological disease treatments, adding it to their food, and as Coca-Cola probably foresees, taking it in their beverages.

In this landscape, CBD supplements would become much more widely available. Consumers will be buying them at big-box discounters like Costco, grocery stores, health food stores, drug stores, and more.

If Brightview’s projection is even partially right, the cannabis companies that can execute on sharp, CBD-focused business plans will make vast fortunes for their investors.

And that’s why we’re here, continuing this conversation about cannabis investing… and why I’m so excited about CBD.

But as I said, the owners of Coca-Cola stock – or even Aurora, for that matter – aren’t going to be the beneficiaries of this market sea change when we look back a few years from now.

It’s going to be in the smaller companies that are just finding market penetration because of constantly improving consumer sentiment and education.

It’s going to be the companies that aren’t yet on the radars of big beverage, big pharma, or big alcohol yet… some of which not even publicly traded.

It’s going to be the companies that resemble penny stocks in price… but not in know-how, experience, and leadership in an industry space that outsiders like Coca-Cola still know far less about.

These winners aren’t easy to find without rolling up one’s sleeves and doing hours and hours of the right kind of research. And not all CBD companies are created even close to equal.

And that’s why we’re going to keep this conversation about cannabis – and specifically, the CBD market – going here in the coming days and weeks. I can’t wait to share more of my research and predictions on this with you.

Buffett just went all-in on THIS new asset. Will you?
Buffett could see this new asset run 2,524% in 2018. And he's not the only one... Mark Cuban says "it's the most exciting thing I've ever seen." Mark Zuckerberg threw down $19 billion to get a piece... Bill Gates wagered $26 billion trying to control it...
What is it?
It's not gold, crypto or any mainstream investment. But these mega-billionaires have bet the farm it's about to be the most valuable asset on Earth. Wall Street and the financial media have no clue what's about to happen...And if you act fast, you could earn as much as 2,524% before the year is up.
Click here to find out what it is.

Want Dividends and Price Upside? 7 Stocks for 162% Returns

If you’re not yet as rich as you hoped you’d be by now, don’t worry – we still have plenty of time to get you there.

And I’m not talking about investing your “growth capital” into risky fly-by-night names like Tesla (TSLA) and Snap (SNAP).

We can scale our money more securely – but just as spectacularly – by purchasing sound dividend payers that happen to be growing their payouts rapidly. Here’s why.

The Most Lucrative Way Shareholders Get Paid

There are three – and only three – ways a company’s stock can pay us:

  1. A cash dividend.
  2. A dividend hike.
  3. By repurchasing its own shares.

Everyone loves the dividend, but investors usually don’t give enough love to the dividend hike. Not only do these raises increase the yield on your initial capital, but also they often are reflected in a price increase for the stock.

For example, if a stock pays a 3% current yield and then hikes its payout by 10%, it’s unlikely that its stock price will stagnate for long. Investors will see the new 3.3% yield, and buy more shares.

They’ll drive the price up, and the yield back down – eventually towards 3%. This is why your favorite dividend “aristocrat” – a company everyone knows and has paid dividends forever – never pays a high current yield. Its stock price rises too fast!

If you don’t believe me, consider 3M (MMM), a “stodgy” company with a ho-hum 2.6% yield. So once inflation bites, you’re left with almost no actual income!

But don’t forget that 3M is a charter member of the Dividend Aristocrats, having hiked its payout for 60 straight years. The connection between its rising dividend and its rising share price is unmistakable.

Check out how the payout drives up the share price at almost exactly the same rate over just about any time period you can imagine, starting with 3 years:

Dividend Up 33%, Shares Up 36%

And then 5 years:

Dividend Up 114%, Shares Up 109%

10 years:

Dividend Up 172%, Shares Up 173%

Since share prices move higher with their payouts, there’s a simple way to maximize our returns: Buy the dividends that are growing the fastest.

The Path to Fast 162% Gains From Safe Blue Chips

Have you always wanted to buy a safe blue chip stock like Coca-Cola (KO) and get rich from it like Warren Buffett?

It’s doable. But most investors “live in the past” and fixate on dividend track records rather than a payout’s forward prospects. And looking ahead is the key to yearly gains of 12%, 27.1% or even 54% or more with blue chip stocks.

(Yes, that’s no exaggeration. It is possible to make 54% annualized gains on a safe blue chip stock. I’ll share an example in a moment.)

Let’s first consider the case of Coke, which achieved its dividend royalty status in 1987 (its 25th straight year with a dividend hike). The firm hit its coronation with a head of steam, rewarding investors with a 362% payout hike in just five years (from 1986 to 1991). Its stock price raced to keep up with its dividend, rising 234% over the same time period:

Great Dividend Growth, Great Returns

It didn’t really matter if you bought shares before or after the company was officially a dividend aristocrat. The driving factor for profits was the dividend’s velocity – it was moving higher quickly, so its stock price followed.

Fast forward to the last five years, and we see that Coke’s youthful exuberance has slowed considerably. The firm still hikes its payout every year, but it’s a slower climb – totaling 45% over the past five years. Which means its stock price merely plods along too (+25% in five years):

Average Dividend Growth, Average Returns

Why is Coke’s dividend slowing down? Simple – just look at the top line.

Shrinking Business is Bad for Payouts

It sounds obvious, but income investors often wade so deep into the dividend weeds that they ignore obvious cues – such as shrinking sales.

Let’s add Coke’s top line into the last chart, and we’ll see that the fact that the payout is growing at all is an act of financial wizardry:

Shrinking Sales Slow the Dividend

Coke’s top line has shrunk by 22% over the last five years. Which makes its dividend growth quite the feat!

Contrast this with the 1986 to 1991 period, when the company was younger and still growing. It boosted its sales by 30% over that time period.

Of course it’s possible to grow payouts faster than profits and sales. In fact, this is what often happens with dividend payers. But even the most gifted managers can only squeeze so much in payouts from a shrinking pie. It’s better to focus on businesses with the winds at their backs.

And That Can Include Spry Blue Chips, Too

Two-and-a-half years ago I told my Hidden Yields subscribers to buy Boeing (BA) because:

  • Its business was booming,
  • Its stock was quite cheap with respect to cash flow, and most importantly
  • Management was plowing profits into payout growth.

Boeing wasn’t a dividend aristocrat like Coke. But it was a much better buy. Here was the tale of the tape in December 2015 (pay special attention to the last column, because it’s the most important):

Boeing vs. Coke (December 2015)

If you want to make real money with stocks, you should always put your money with the faster dividend grower. Boeing was no exception – its two massive dividend raises in the last two years have sent the stock soaring to 150% total returns:

Boeing Soars With Its Payout

Our secret, as usual, is we purchased the payout that was growing the fastest. We enjoyed a 57% cumulative “raise” from Boeing, which in turn rocketed its stock price higher.

Since share prices move higher with their payouts, there’s a simple way to maximize our returns: Buy the dividends that are growing the fastest.

7 Dividend Growers to Buy Now (for 162%+ Upside)

How much money should you allocate to dividend growth?

As you can see – as much as possible. This strategy is such a “slam dunk” for investing returns that there’s no reason to collect more current yields than you need right now. If you can “forego” some amount of income today, I would encourage you to consider investing that capital into dividend growers.

It’s a simple three-step process:

Step 1. You invest a set amount of money into one of these “hidden yield” stocks and immediately start getting regular returns on the order of 3%, 4%, or maybe more.

That alone is better than you can get from just about any other conservative investment right now.

Step 2. Over time, your dividend payments go up so you’re eventually earning 8%, 9%, or 10% a year on your original investment.

That should not only keep pace with inflation or rising interest rates, it should stay ahead of them.

Step 3. As your income is rising, other investors are also bidding up the price of your shares to keep pace with the increasing yields.

This combination of rising dividends and capital appreciation is what gives you the potential to earn 12% or more on average with almost no effort or active investing at all.

Editor's Note: The stock market is way up – and that’s terrible news for us dividend investors. Yields haven’t been this low in decades! But there are still plenty of great opportunities to secure meaningful income if you know where to look. Brett Owens' latest report reveals how you can easily (and safely) rake in 8%+ dividends and never worry about drawing down your capital again. Click here for full details!